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Abstract  We report the solid phase synthesis of –GG-X-GG– type α/β-carbopeptoids incorporating RibAFU(ip) (1a, tX) 
or XylAFU(ip) (2a, cX) sugar amino acids. Though coupling efficacy is moderate, both the lengthier synthetic route using 
Fmoc deriva-tive (e.g., Fmoc-RibAFU(ip)-OH) and the azido deriva-tive (e.g., N3-RibAFU(ip)-OH) via Staudinger 
reaction with nBu3P can be successfully applied. Both X-ray dif-fraction, 
1
H- and 
31
P-NMR, and theoretical (QM) data 
support and explain why the application of Ph3P as Staudinger reagent is “ineffective” in the case of a cis stereoisomer, if 
cX is attached to the preceding residue with a peptide (–CONH–) bond. The failure of the poly-peptide chain elongation 
with N3-cX originates from the “coincidence” of a steric crowdedness and an electronic effect disabling the mandatory 
nucleophilic attack dur-ing the hydrolysis of a quasi penta-coordinated triph-enylphosphinimine. Nevertheless, the 
synthesis of the above α/β-chimera peptides as completed now by a new pathway via 1,2-O-isopropylidene-3-azido-3-
deoxy-ribo-and -xylo-furanuronic acid (H-RibAFU(ip)-OH 1a and H-XylAFU(ip)-OH 2a) coupled with N-protected α-
amino acids on solid phase could serve as useful examples and starting points of further synthetic efforts.
 
Introduction 
 
Oligopeptides containing β-amino acids have become 
increasingly popular in foldamer chemistry and drug research. 
The enzyme resistance of α/β-peptides, coupled to their 
inherent feature of self-assembly (Beke et al. 2008) and a 
propensity for forming nanostructures, initiated stud-ies of 
particular importance, with different β-amino acids of 
modified side chains used as protein mimetics (Cheng et al. 
2001; Hecht and Huc 2007; Horne and Gellman 2008; Pilsl 
and Reiser 2011; Guichard and Huc 2011; Martinek and 
Fülöp 2012; Cabrele et al. 2014; Mándity and Fülöp 2015). β-
Amino acid building blocks of cyclic skeleton are of special 
interest, as the ring structure puts constraint on the central θ-
backbone torsional angle adjacent to ϕ and ψ and thus 
stabilizes specific secondary structural elements (Beke et al. 
2004). Recently, sugar amino acids (SAA), par-ticularly, five- 
or six-membered cyclic amino sugar carbox-ylic acids, 
appeared as appropriate building blocks for car-bopeptoid 
foldamers (Herradón and Seebach 1989; Kessler et al. 1995; 
Long et al. 1999; Simone et al. 2005; Sharma et al. 2008, 
2011; Andreini et al. 2009). Numerous furanoid 
 
and pyranoid carbohydrate analogs of trans-2-amino-
cyclo-pentane carboxylic acid (trans-ACPC) and trans-2-
amino-cyclohexane carboxylic acid (trans-ACHC) were 
synthe-sized and built into homo- and heterooligomers to 
test their self-assembling abilities (Pandey et al. 2011; Giri 
et al. 2012; Risseeuw et al. 2013).  
Amino furanuronic acids (AFUs, Fig. 1) and their 
homooligomers are part of several bioactive macromol-
ecules (Gruner et al. 2001, 2002a; Chandrasekhar et al. 
2009). Among them, H-RibAFU(ip)-OH, (1a) (Gruner et 
al. 2002b) and its xylo epimer H-XylAFU(ip)-OH (2a) 
(Chandrasekhar et al. 2004) as hydrophilic analogs of cis- 
and trans-ACPC monomers were incorporated into β-
peptidic heterooligomers. Derivatives of the two epimers 
are preferred building blocks, as they can be synthesized 
from d-glucose. Furthermore, the relatively rigid conforma-
tion of the furanoid ring, in between the ϕ and ψ torsional 
angles, might give the right amount of internal flexibility  
θ ~ 60 ± 30° to the appropriately protected derivatives. 
Syntheses of the homo- or heterooligomers of furanoid   
sugar amino acids (AFUs) were performed, hitherto, with 
conventional methods of peptide synthesis starting from 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1  Direct coupling of the “starting” azido compound (1b) followed by reduction provides in two steps (A route: 1b → 3b → 3a) the 
very same product as the “conventional” Fmoc-strategy that provides in four consecutive steps (B route: 1b → 1a → 1c → 3c → 3a) 
 
various Fmoc- or Boc-protected AFU derivatives obtained 
from the corresponding azido-deoxy-furanuronic acids 
with catalytic hydrogenation and simultaneous Fmoc pro-
tection without isolation of the free β-amino acids (Gruner 
et al. 2002b; Chandrasekhar et al. 2004). Since the N3 
group could be considered as a “masked” NH2 function-
ality, 3-azido-3-deoxy-furanoid intermediates should also 
be used, in principle, as temporary N-protected deriva-tives 
for direct peptide couplings. The reduction of the N3 
functionality after peptide bond formation—once cou-pling 
is completed—would result in the shortening of the 
synthetic pathway (the two-step route of 1b → 3b → 3a) 
omitting the Fmoc protection/deprotection steps for each of 
the monomeric unit (Scheme 1) during the lengthier  
1b → 1a → 1c → 3c → 3a route.  
Similar results might be expected from the xylo epimer 
2b on analogous pathways of giving product 4a (Scheme 
2).  
This shortening of the reaction pathway, however, gives 
rise to difficulties during the catalytic hydrogenation of one 
N3 group in the oligopeptides, particularly, during peptide 
 
 
Scheme 2  The “starting” xylo epimer azido-compound (2b) and the 
related product (4a) 
 
 
 
 
bond formation in the solid phase. Generally, problems 
arising from heterogenic phase hydrogenation can be over-
come by reducing the azido group of a pentofuranuronic 
building block with tertiary phosphines under well-estab-
lished conditions of the Staudinger reaction (Staudinger 
and Meyer 1919; Staudinger and Hauser 1921; Leffler and 
Temple 1967; Gololobov et al. 1981; Gololobov 1992; 
Simone et al. 2005; Brase et al. 2005; Van Rompaey et al. 
2005; Temelkoff et al. 2006): a method introduced for 
azidosugars as early as 1964 (Messmer et al. 1964). The 
applicability of the Staudinger reaction in peptide chemis-
try was confirmed in the early 2000s (Saxon et al. 2000; 
Nilsson et al. 2000), and its applicability to solid phase 
synthesis was shown in the same year (Malkinson et al. 
2000; Lundquist and Pelletier 2001). Staudinger ligation 
became a very useful technique in the field of bioconjuga-
tion methods (Schilling et al. 2011). An alternative could 
have been a 1,4-dithiothreitol (DTT)-mediated reduction 
on solid phase (Meldal et al. 1997; Tornøe et al. 2000); 
how-ever, both reaction conditions (higher T, e.g., 50 °C) 
and the requested reaction time make the latter reaction 
less favored.  
Here, we present studies comparing the efficiency of A and 
B routes (Scheme 1) in making new –GG-X-GG– type 
pentapeptides, models used for studying the conforma-tional 
propensities of oligopeptides (Shi et al. 2005, Beck et al. 
2008), where X is either RibAFU(ip) (1a, tX) or XylAFU(ip) 
(2a, cX). Comparing synthetic routes, yields, etc., we could 
elucidate the stereochemical influence of the trans(ribo) and 
cis(xylo) configuration both on the reduc-tion of the azido 
group and subsequent peptide bond for-mation. To our great 
surprise the phosphinimino group on the furanoid building 
block of cis (and only cis) conforma-tion proved unexpectedly 
stable. Although recently John and Wittmann (2015) 
published the reduction of a 3-azido-3-deoxy-ribofuranoid 
building block in a tetrapeptide with Me3P, the unexpected 
stability of the intermediate phos-phinimino group demands 
explanation. We present a model based on X-ray diffraction, 
spectroscopic and theoretical (QM) data and describe multiple 
routes that allow efficient synthesis of α/β-heterooligopeptides 
in solid phase. 
 
 
Experimental 
 
Reagents and instrumentations 
 
Reagents, starting materials and solvents were obtained 
from Alfa Aesar, Sigma-Aldrich, Merck, Reanal or VWR. 
Fmoc–Gly–Gly–OH was purchased from Reanal Private 
Ltd. For moisture-sensitive reactions, the solvents were 
distilled with standard procedures or dried by molecu-lar 
sieves in vacuo. Hydrogenation reactions were carried out 
in an H-Cube
®
 and H-Cube Mini™ continuous-flow 
reactors (ThalesNano Inc, Budapest, Hungary). Column 
chromatography was performed on Kieselgel 60 silica gel 
(0.040–0.063 mm; Merck) with eluents indicated in the 
experiments. Reactions were monitored by thin-layer chro-
matography on Kieselgel 60 F254 (E. Merck). The plates 
were developed by UV detection (254 nm) and charring 
with aqueous sulfuric acid solution. Melting points were 
defined with a Boetius microscope apparatus. Optical 
 
rotations were measured by Carl Zeiss Jena Polamat A 
polarimeter. The products were analyzed by reverse-phase 
HPLC on a Phenomenex Jupiter C-18 column using water/ 
acetonitrile mixtures of 0.1 % TFA in water (A) and 0.08 % 
TFA, 95 % acetonitrile in water (B) and UV detection at 220 
and 280 nm. Some products were lyophilized and examined 
with Bruker Esquire 3000+ tandem quadru-pole mass 
spectrometer equipped with an electrospray ion source. The 
elemental analysis was performed on VARIO EL (Elementar 
Analysensysteme GmbH, Hanau, Germany) instrument. FTIR 
spectra were recorded with Bruker IFS 28 spectrometer by the 
ATR technique. 1D 
13
C- and 
31
P-NMR spectra were 
measured with Bruker Avance 250 spec-trometer in CDCl3, 
D2O, CD3OD and DMSO-d6 at room temperature. 2D NMR 
spectra were recorded with Bruker Avance-III 700 
spectrometer at 288 K. Deuterated solvents were purchased 
from Sigma-Aldrich. The one-crystal dif-fraction data were 
recorded with a PANanalyticalXpert Pro MPD XRD X-ray 
diffractometer with X’celerator detector at the Budapest 
University of Technology and Economics. 
 
Peptide synthesis 
 
2-Chlorotrityl chloride resin was swollen in DCM. It was 
washed three times with DCM (10 mL/g resin) at room 
temperature. The Fmoc–Gly–Gly–OH (3 equiv. to the 
nominal capacity of the resin ~1.0 mmol/g) was dis-solved 
in DMF/THF 1:1 and DIEA (1 equiv.) was added to the 
solution. The reaction mixture was dropped slowly into the 
resin syrup after DIEA (2 equiv.) was added again. The 
reaction was allowed for 4 h or overnight. The resin was 
washed with 3× DCM, 3× iPrOH and 1× diethyl ether, and 
dried in vacuo. The capacity of the resin was determined 
by spectrometric measurement of the amount of Fmoc 
chromophore (Fmoc-piperidine adduct) released upon 
treatment of the resin with 20 % piperidine/DMF (Chan 
and White 2000).  
The Fmoc group was removed by 2 % piperidine and 2 
% DBU in DMF. The successful cleavage was analyzed by 
Kaiser test.  
The synthesis of the model pentapeptides was contin-
ued by Fmoc chemistry using DIC/HOBt or HATU/DIEA 
methods with repeated coupling if necessary. THF was 
used as cosolvent in the case of 1b and 2b.  
After coupling the two azido derivatives (1b and 2b), 
the efficiency was monitored by elemental analysis (N 
content).  
The bench-scale test cleavage and the final cleavage 
from resin were carried out with DCM:MeOH:AcOH 8:1:1 
mixture (5–10 mL/g resin) for 2 h. Resin was washed with 
3× THF, 2× DMF, 2× iPrOH, 2× DMF, 2× iPrOH, 2× 
MeOH and 1× diethyl ether. The solvent was removed in 
vacuo. Depending on the peptides, the crude product was 
precipitated with DCM/diethyl ether, EtOAc/hexane mix-
tures or lyophilized with dissolving water. 
 
1,2‑O‑Isopropylidene‑3‑amino‑3‑deoxy‑α‑d‑ribofuranuro 
nic acid (1a) 
 
1 , 2 - O - I s o p r o p y l i d e n e - 3 - a z i d o - 3 - d e o x y - 
α - d - ribofuranuronic acid (1b, 0.50 g, 2.18 mmol) was dis-
solved in dry pyridine (230.3 mL) and triphenylphosphine 
(1.262 g, 4.81 mmol) was added. The reaction mixture was 
allowed to stand for 2 h at room temperature. Ammonium 
hydroxide solution (25 %, 8.8 mL) was dropped to the mix-
ture and it was allowed to stand for 3.5 h. The solution was 
filtered and concentrated in vacuo, the residue was treated 
with aqueous ammonia (12 %) and the solid containing Ph3P 
and Ph3PO was removed by filtration. Evaporation of the 
filtrate furnished the crude product which was tritu-rated with 
petroleum ether to give 1a as pale yellow solid (0.412 g, 
conversion: 82 %, yield: 93 %). IR: 3170, 2750– 2460, 2170–
1900, 1605 cm
−1
. ESI-MS: [M+H] 204.1 m/z. 
1
H-NMR 
(CDCl3, 250 MHz): δ ppm 6.49 (broad m, N–H),  
5.82 (d, J1,2 = 3.4 Hz, 1H, H-1), 4.69 (t, J2,3 = 4.5 Hz, 1H, 
H-2), 4.45 (d, J3,4 = 9.5 Hz, 1H, H-4), 3.64 (dd, J2,3 = 4.5 
Hz, J3,4 = 9.5 Hz, 1H, H-3), 1.54 and 1.34 (s, 
isopropylidene CH3). 
 
N‑9‑Fluorenylmethyloxycarbonyl‑1,2‑O‑isopropylidene‑3‑ 
amino‑3‑deoxy‑α‑d‑ribofuranuronic acid (1c) 
 
1,2-O-Isopropylidene-3-azido-3-deoxy-α-d-ribofuranuronic 
acid (1b 0.255 g; 1.11 mmol) was dissolved in methanol (c = 
35 mmol/l) and reduced with H2 on 10 % Pd/C by H-Cube
®
 
reactor (parameters: 60 °C; 10 bar; 0.2 mL/min). After the 
reaction, the solution was concentrated in vacuo to give the 
product. The product is a pale yellow solid (0.20 g; 88 %). Rf: 
0.51 (chloroform–methanol 3:2). FTIR–ATR: νmax: 3170 (ν 
NH3
+
), 2750–2460 and 2170–1900 diffuse (ν NH3
+
), 1605 (ν 
COO–) cm
−1
. ESI-MS: 204,1 [M+H]
+
, fragment 146,2 
[M+H-58]
+
; 202,0 [M−H]-; calculated: 203,19 m/z. 
1
H NMR 
(D2O, 250 MHz): δ 6,035 (d, 1H, H-1,  
J1,2 = 3.7 Hz); 4,97 (t, 1H, H-2, J2,3 = 4.6 Hz); 4,43 (d, 
1H, H-4, J3,4 = 10.1 Hz); 3,68 (dd, 1H, H-3, J2,3 = 4.6 Hz, 
J3,4 = 10.1 Hz), 1,58 (s, 3H, CH3), 1,39 (s, 3H, CH3) ppm.  
The stirred solution of 1,2-O-isopropylidene-3-amino-3-
deoxy-α-d-ribofuranuronic acid (0.20 g; 0.99 mmol) in 
methanol–water 2:1 (6.6 mL) is adjusted to pH 8 with satu-
rated NaHCO3 solution. The solution of Fmoc-OSu (0.37 
g; 1.1 mmol; 1.1 equiv.) in THF (6.8 mL) was added to 
this solution and stirred for 48 h at room temperature. Sol-
vents were removed in vacuo. The residue was suspended 
in water and extracted with EtOAc (3×). The combined 
organic phases were washed with NaHCO3. The aqueous 
phase is adjusted to pH 1 with 2 N HCl and extracted with 
 
EtOAc (3×). The organic phase is washed with saturated 
NaCl solution, dried (MgSO4) and concentrated in vacuo. 
The product is a white solid (0.21 g; yield: 45 %). Rf: 0.50 
(ethyl acetate–methanol 4:1); ESI-MS: 426.2 [M+H]
+
; 
calculated: 425.19 m/z. 
 
N‑Methyl‑1,2‑O‑isopropylidene‑3‑amino‑3‑deoxy‑α‑d‑ 
ribofuranuronamide (3a) 
 
(A) N-Methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-d-
ribofuranuronamide (3b, 0.054 g, 0.223 mmol) was dis-solved 
in a mixture of THF (3 mL) and methanol (1 mL). After 
stirring for 30 min under N2, triphenylphosphine (0.088 g, 
0.336 mmol) in THF (2 mL) and aqueous ammo-nium 
hydroxide (2 mL) were added to the reaction mixture. After 
stirring for 1.5 days, diluted aqueous ammonia (10 %) was 
added again to precipitate a mixture of Ph3P and Ph3PO. 
After filtration, the crude product was separated and 
recrystallized from ethyl acetate to give pure 3a (0.037 g, 
conversion: 69 %, yield: 77 %); m.p.: 170–173 °C. Rf: 0.86 
(chloroform–methanol 3:1). FTIR–ATR: 3375, 3353, 1652, 
1545 cm
−1
. ESI-MS: [M+H] 217.2 m/z. 
1
H-NMR (CDCl3, 
250 MHz): δ ppm 6.47 (broad m, 1H, NH-CH3), 5.77 (d,  
J1,2 = 3.4 Hz, 1H, H-1), 4.57 (t, J2,3 = 4.4 Hz, 1H, H-2), 
4.06 (d, J3,4 = 9.5 Hz, 1H, H-4), 3.12 (dd, J2,3 = 4.4 Hz, 
J3,4 = 9.5 Hz, 1H, H-3), 2.77 (d, JNH-CH3 = 5.0 Hz, 3H, 
amide-CH3), 1.47 and 1.27 (s, isopropylidene CH3).  
(B) N-Methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-
d-ribofuranuronamide (3b) (0.161 g, 0.665 mmol) was 
dissolved in dry pyridine (6 mL) and triphenylphosphine 
(0.338 g, 1.29 mmol) was added. The reaction mixture was 
made to stand for 2 h at room temperature. Then, aqueous 
ammonia (2.3 mL) was added and the mixture was left to 
stand for 2.5 h. The precipitate was filtered and the filtrate 
was concentrated in vacuo. Aqueous ammonia (10 %) was 
added again to precipitate a mixture of Ph3P and Ph3PO. 
After filtration and evaporation of the filtrate, the crude 
product was recrystallized from ethyl acetate to give pure 
3a (0.132 g, conversion: 82 %, yield: 92 %). Rf: 0.86 
(chloroform–methanol 3:1). The spec-tral and 
chromatographic data are identical with those of product 
A). 
 
1,2‑O‑Isopropylidene‑3‑amino‑3‑deoxy‑α‑d‑xylofuranuro 
nic acid (2a) 
 
1,2-O-Isopropylidene-3-azido-3-deoxy-α-d-xylofuranuronic 
acid (2b, 0.937 g, 4.0 mmol) was dissolved in dry pyri-
dine (35 mL) and triphenylphosphine (1.7 g, 6.4 mmol) 
was added. The mixture was stirred for 2–3 h at room tem-
perature until TLC (hexane:EtOAc 1:4) indicated no start-
ing compound and a solid precipitated. Aqueous ammonia 
(25 %, 13.2 mL) was added and stirring was continued 
 
for 2 h. The solid was filtered and the filtrate was concen-
trated in vacuo to give the crude product containing 2a and 
Ph3PO. The mixture was dissolved in dichloromethane, and 
ethyl acetate was added to precipitate a cream-colored solid. 
After filtration, the solid was triturated with methanol to 
afford pure 2a as a white powder (0.763 g, conversion: 81 %, 
yield: 94 %), m.p.: >235°C. FTIR–ATR: 2977, 2465, 1637, 
1560 cm
−1
. ESI-MS: [M+H] 204.2 m/z. RP-HPLC: 18.7 min. 
1
H-NMR (D2O, 250 MHz): δ ppm 6.10–6.08 (H-1), 4.76–
4.74 (H-4), 3.97–3.95 (H-2), 3.31–3.29 (H-3), 1.50 and 1.30 
(s, isopropylidene CH3). 
 
1,2‑O‑Isopropylidene‑3‑deoxy‑3‑triphenylphosphinimino‑ 
α‑d‑xylofuranuronic acid (2g) 
 
1,2-O-Isopropylidene-3-azido-3-deoxy-α-d-xylofuranuronic 
acid (2b, 0.13 g, 0.56 mmol) was dissolved in dry THF (3 
mL), and triphenylphosphine (0.163 g, 0.62 mmol) was 
added. The reaction mixture was stirred for 2 h at room tem-
perature until TLC (EtOAc:MeOH 4:1) indicated no starting 
compound. The solution was concentrated in vacuo to give a 
brown solid which was dissolved in THF again and dropped 
into hexane (20 fold volume). Filtration gave jonquil crys-tals 
(2g) (0.064 g, conversion: 49 %, yield: 25 %), m.p.: 132–
136°C; Rf = 0.24 (MeOH:EtOAc 1:2). RP-HPLC: 14.58 min. 
ESI-MS: [M+H]: 464.3 m/z. FTIR–ATR: 2977, 2465, 1637, 
1560 cm
−1
. 
1
H NMR (CDCl3, 250 MHz): δ ppm 7.76–7.39 
(aryl-H), 6.06 (H-1), 4.57 (H-4), 4.06 (H-2), 3.74–3.73 (H-3), 
1.50 and 1.03 (s, isopropylidene CH3). 
31
P NMR 
(CDCl3, 250 MHz): δ ppm 29.23 (N=PPh3). 
 
N‑Methyl‑1,2‑O‑isopropylidene‑3‑amino‑3‑ 
deoxy‑α‑d‑xylofuranuronamide (4a) 
 
N-Methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-d-
xylofuranuronamide (4b, 0.05 g, 0.2 mmol) was dis-solved 
in pyridine (1 mL); then tributylphosphine (53.2 µL, 0.21 
mmol) was added with syringe to the solution. The 
reaction mixture was stirred for 1.5 h. Dilution with water 
and addition of aqueous ammonia (25 %) resulted in a 
solid. After filtration and evaporation of the filtrate, the 
treatment of the residue was repeated to give a syrupy 
crude product which was purified by column flash 
chromatogra-phy with an eluent mixture EtOAc:MeOH 
9:1. The fraction of high polarity (Rf ~ 0.1) afforded pure 
4a as white solid (0.015 g, conversion: 30 %, yield: 35 %), 
m.p.: >300°C. FTIR–ATR: 3403, 1683, 1412 cm
−1
. ESI-
MS: [M+H] 217.2 m/z. RP-HPLC 19.1 min. 
1
H NMR 
(D2O, 250 MHz): δ ppm 6.03–6.02 (H-1), 4.04–4.01 (H-4), 
3.65–3.63 (H-2), 2.68–2.66 (H-3), 1.95 (NH-Me), 1.44 and 
1.26 (s, isopro-pylidene CH3). 
 
N‑Methyl‑1,2‑O‑isopropylidene‑3‑deoxy‑3‑ 
triphenylphosphinimino‑α‑d‑xylofuranuronamide (4g) 
 
N-Methyl-1,2-O-isopropylidene-3-azido-3-deoxy-α-d-
xylofuranuronamide (4b, 0.3 g, 1.23 mmol) was dissolved in 
diethyl ether (3 mL); then triphenylphosphine (0.38 g, 1.44 
mmol, 1.2 equiv.) was added. After stirring for 2 h, the 
reaction mixture was concentrated in vacuo and the resi-due 
was dissolved in ether (1 mL) and dropped into hexane 
(tenfold volume) to precipitate the product, which was fil-
tered to give crystals of pure 4g (0.045 g, conversion: 15 %, 
yield: 8 %), m.p.: 93–95°C; Rf = 0.22 (EtOAc:MeOH 9:1). 
ESI-MS: [M+H] 477.3 m/z. RP-HPLC: 18.81. FTIR– ATR: 
3345, 2985, 1669, 1543 cm
−1
. 
1
H NMR (d4-MeOH, 250 
MHz): δ ppm 5.99–5.97 (H-1), 4.72–4.71 (H-4), 3.98– 3.97 
(H-2), 3.94–3.93 (H-3), 2.77 (NH-Me), 1.41 and 1.24 (s, 
isopropylidene CH3). 
31
P NMR: δ ppm 29.1 (N=PPh3). 
 
N‑Methyl‑1,2‑O‑isopropylidene‑3‑deoxy‑ 3‑
triphenylphosphiniminio‑α‑d‑xylofuranuronamide 
chloride (4g·HCl) 
 
To the solution of N-methyl-1,2-O-isopropylidene-3-azido-
3-deoxy-α-d-xylofuranuronamide (4b, 1.0 g, 3.8 mmol) in 
methanol (40 mL) triphenylphosphine (1.59 g, 6.0 mmol) 
was added. Methyl tert-butyl ether was dropped to the 
reaction mixture until dissolution of triphenylphosphine. 
The mixture was stirred for 2–3 h at room temperature and 
then water was dropped into the solution until a precipi-
tate appeared; then stirring was continued for 2–3 h. The 
mixture was filtered and the filtrate was concentrated in 
vacuo. Methanol was added to the residue and the undis-
solved solid was filtered again. The filtrate was concen-
trated and traces of water were removed by evaporation of 
propanol-2. The residue was dissolved in methyl tert-butyl 
ether (50 mL); the solution was acidified to pH 2–3 with 6 
N methanolic hydrochloric acid and stirred overnight. The 
separated cream-colored solid was filtered to give crude 
4g·HCl (0.7 g, conversion: 70 %, yield: 36 %), m.p.: 
>235°C; Rf = 0.21 (EtOAc:MeOH 4:1); [α] D
25
 −75 (c 1, 
EtOH). RP-HPLC: 15.37 min (R-N = PPh3). FTIR–ATR: 
νmax: 3330, 2983, 1807, 1754, 1702, 1526 cm
−1
. 
1
H NMR 
(d4-MeOH, 250 MHz): δ ppm 6.12–6.11 (H-1), 4.64–4.62 
(H-4), 4.53–4.51 (H-2), 3.64–3.58 (H-3), 2.65 (NH-Me), 
1.30 and 1.20 (s, isopropylidene CH3). 
13
C NMR (d4-
MeOH, 250 MHz): δ 169.9 (C-5), 114.07 (C-7), 106.36 (C-
1), 86.3–86.2 (C-2), 81.14–81.05 (C-4), 61.31 (C-3), 26.87 
(C-6), 26.43–26.24 (C-8 and C-9). 
31
P NMR: δ ppm 40.55 
(NH
+
=PPh3). A sample of the crude 4g·HCl was 
recrystallized from methanol to give large crystals appro-
priate for X-ray diffraction analysis. 
 
N,N‑Dimethyl‑1,2‑O‑isopropylidene‑3‑amino‑ 
3‑deoxy‑α‑d‑xylofuranuronamide (5a) 
 
To the solution of N,N-dimethyl-1,2-O-isopropylidene-3-
azido-3-deoxy-α-d-xylofuranuronamide (5b, 0.29 g, 1.13 
mmol) in dry pyridine (3 mL) triphenylphosphine (0.326 g, 
1.24 mmol) was added and the reaction mix-ture was standing 
for 2 h at room temperature. Water was added dropwise until 
a precipitate appeared, then aqueous ammonia (25 %) was 
added to the mixture and was left to stand overnight. The solid 
was filtered and the filtrate was concentrated in vacuo to give 
a drab solid containing 5a and Ph3PO. After repeated 
treatment of this mixture with aqueous ammonia, finally, the 
components were separated by flash column chromatography 
(ethyl acetate:methanol 9:1). The combined fractions 
containing the product were concentrated to give 5a as a 
brown oil (0.13 g, conver-sion: 45 % yield: 50 %); Rf: 0.28 
(EtOAc:MeOH 2:1); 
24.7° (c 0.85, CHCl3). FTIR–ATR: 3296, 2986,  
1644 cm
−1
. ESI-MS: [M+H] 231.2 m/z. RP-HPLC: 2.86, 
7.58, 18.9. 
1
H-NMR (250 MHz, CDCl3): δ ppm 5.89–5.87 
(H-1), 4.72–4.71 (H-4), 4.3–4.29 (H-2), 3.56–3.55 (H-3), 
2.97–2.83 (NMe2), 1.89 (NCH3), 1.36 and 1.17 (s, iso-
propylidene CH3). 
13
C NMR (CDCl3, 250 MHz): δ ppm 
 [α]
24
D
.5
 
167.72 (C=O), 111.44 (C-NMe2), 104.45 (C-1), 85.58 (C-
2), 77.91 (C-4), 58.27 (C-3), 36.9, 35.6 (N-CH3), 26.6, 
25.9 (CH3). 
 
N,N‑Dimethyl‑1,2‑O‑isopropylidene‑3‑deoxy‑3‑triphe 
nylphosphinimino‑α‑d‑xylofuranuronamide (5g) and N,N‑ 
dimethyl‑1,2‑O‑isopropylidene‑3‑amino‑3‑deoxy‑α‑d‑ 
xylofuranuronamide (5a) 
 
To the solution of N,N-dimethyl-1,2-O-isopropylidene-3-
azido-3-deoxy-α-d-xylofuranuronamide (5b, 0.30 g, 1.16 
mmol) in diethyl ether (3 mL), triphenylphosphine (0.335 
g, 1.27 mmol) was added. After standing for 2 h at room 
temperature, the reaction mixture was concen-trated in 
vacuo. The residue was dissolved in ether (1 mL) and 
dropped into hexane (tenfold volume); it was then allowed 
to stand overnight at 0 °C when crystals of 5g separated 
(0.029 g, conversion: 10 %); m.p.: 60–64 °C; Rf: 0.2 
(EtOAc:MeOH 4:1). FTIR–ATR: 3227, 2931, 1643, 1436 
cm
−1
. ESI-MS: [M+H] 491.4 m/z. RP-HPLC: amine 
14.47, two phosphinimine conformers 18.89 and 28.31; 
1
H 
NMR (250 MHz, CDCl3): (a) iminophosphorane major 
conformer δ ppm 7.63–7.50 (aryl-H), 5.96–5.94 (H-1), 
4.78–4.77 (H-4), 4.36–4.34 (H-2), 4.98–4.96 (H-3), 3.04 
and 2.90 (2 NMe), 1.44 (s, 3H, CH3), 1.25 (s, 3H, CH3);  
(b) iminophosphorane minor conformer δ ppm 7.47–7.37 
(aryl-H), 5.90–5.89 (H-1), 4.95–4.94 (H-4), 4.51–4.49 (H-
2), 4.89–4.87 (H-3), 2.99 and 2.87 (2 NMe), 1.44 and 1.22 
(2 CH3) ppm; (c) amino compound δ ppm 6.24–6.22 
(H-1), 4.89–4.86 (H-4), 4.29–4.28 (H-2), 3.64–3.63 (H-3), 
2.72 and 2.53 (2 NMe), 2.16 (C
3
-NH2), 1.36 and 1.17 (s, 
isopropylidene CH3). 
 
Computation methods 
 
Calculations were carried out using the Gaussian09 soft-
ware (Gaussian 09, Frisch et al. 2009). The lowest energy 
conformers were obtained by completing the appropriate 
scans around the psi torsional for compounds 2g, 4g and 
5g at B3LYP/6-31+G(d) level of theory. The final geom-
etry optimization and frequency calculations were done at 
the B3LYP/6-311++G(d,p) level, both in vacuo and in 
water (IEFPCM solvent model). Natural bond orbital 
(NBO) analysis was performed using the NBO 5.9 
program (Glendening et al. 2001), using the in-house 
developed vis-ualization module. 
 
 
Results and discussion 
 
The syntheses of precursors N3-RibAFU(ip)-OH (1b) and 
N3-XylAFU(ip)-OH (2b) was completed using partly the 
well-known general pathways starting from d-glucose 
(Gruner et al. 2002b; Chandrasekhar et al. 2004). The 2-
chlorotrityl chloride (2-Cl-Trt) resin was used as it offers 
the advantage of easy ligation of the first amino acid with 
ester bond and then after the final coupling the easy cleav-
age of the polypeptide under mild acidic conditions (Bar-
los et al. 1991; Kocsis et al. 2006; García-Martín et al. 
2007). Determination of theoretical capacity and coupling 
efficiency of the resin was completed by elementary anal-
ysis (N %) and measurement of Fmoc capacity (Table 1). 
The first two glycine moieties were linked to the resin in 
the usual manner with Fmoc-GG-OH, followed by the sub-
sequent removal of Fmoc protection. Ligation of both 1b 
and 2b was performed to the free N-terminus of the second 
Gly, either with the DIC/HOBt or HATU/DIEA coupling 
method in DMF:THF(1:1). Successful formation of azide 
intermediates 1d and 2d was established with bench-scale 
test cleavages giving 1e and 2e α/β-tripeptides, the struc-
ture of which was corroborated by the N3 band at the IR 
spectrum (2113–2116 cm
−1
).  
Subsequent treatment of the sterically hindered 2d with 
Ph3P in THF/MeOH at room temperature provided Ph3P=N-
cXGG-Resin. Formation of it was shown by acidic cleavage 
of a portion from the resin giving Ph3P=N-cXGG-OH: 
supported by the appearance of the singlet peak at 40.5 ppm 
(
31
P-NMR) and the lack of the N3 IR band. To get the 
appropriate amine, 2h, several attempts were car-ried out 
under usual conditions with NH4OH. However, hydrolysis 
was unsuccessful even if stronger bases, like tri-ethylamine 
(TEA), N,N-diisopropylethylamine (DIEA) and 
 
 
Table 1  Selected analytical measures of the solid phase synthesis of 
pentapeptides: on-resin coupling and efficiency 
 
Cl-Trt resin Coupling with: Fmoc-GG-OH       
 
 Resin capacity 0.59          
 
 (mmol/g)a           
 
H-GG-Trt Coupling with: 1b    2b    1c  
 
resin N-content (%) 3.15 b 3.59 c 2.27 b 2.30 c 2.13 c  
       
 Residual 0.45  0.51  0.32  0.33  0.51  
 
 capacity           
 
 (mmol/g)           
 
 Efficiency of 76  86  54  56  86  
 
 coupling           
 
 (%)d           
 
N-term depro- Efficiency of 31  37  27  18  >90  
 
tection –NH2 forma-            
 tion (%)e,f           
 
H-XGG-Trt Coupling with: Fmoc-GG-OH       
 
resin Residual 0.067 0.091 0.042 0.028 0.25   
   
 capacity           
 
 (mmol/g)a           
 
 Apparent 15  18  13  9  49  
 
 efficiency           
 
 of coupling           
 
 (%)d           
 
Fmoc- Overall effi- 11  15  7  5  42  
 
GGXGG- ciency (%)           
 
Trt resin            
 
 
a
  Fmoc capacity 
b
  DIC/HOBt coupling 
c
  
HATU/DIEA coupling  
d
  2 equiv. reagent used, unless mentioned 
otherwise 
e
  nBu3P/OH or piperidine  
f
  Estimated based on back-calculations 
 
ethanolic KOH were used. The unexpectedly high stability 
of the intermediate triphenylphosphinimine impeded the 
formation of 2h and, thus, the forthcoming peptide bond 
formation. Unlike Ph3P, when the more reactive nBu3P 
was used (Scheme 3), reduction of N3– was achieved. The 
application of the Me3P (John and Wittmann 2015) was 
omitted as it is an expensive and hazardous reagent, and 
thus unfit for large scale production. Furthermore, 1d gave 
Ph3P=N-tXGG with Ph 3P in THF/MeOH at room tem-
perature, hydrolyzed to 1h, leading to the conclusion that 
in case of the trans isomer the nucleophilic attack on the P-
atom is easy to achieve (see below).  
Regardless of the local cis or trans configuration of X, 
both 1d and 2d with nBu3P in THF-MeOH 1:1 gave 
nBu3P=N-intermediates which could be hydrolyzed with 
TEA and DIEA in the same solvent to give 1h and 2h, 
respectively. Bench-scale test cleavages gave intermediates 
H-tXGG-OH (1i) and H-cXGG-OH (2i) characterized by 
IR bands of –CONH– and –NH2 groups in the region of 
1665–1663, 1596–1541, 1460–1445 cm
−1
 and, at the same 
 
time, by the absence of the –N3 band. In accordance, no 
signal was found in 
31
P-NMR, revealing the 100 % 
conver-sion to 1h and 2h (no traces of phosphinimines 
were pre-sent after hydrolysis). Coupling of both 1h and 
2h with Fmoc-GG-OH gave Fmoc-GGtXGG-Resin and 
Fmoc-GGcXGG-Resin intermediates (Table 1) converted 
directly into the final products. Identification of both 
pentapeptides, H-GGtXGG-OH (1j) and H-GGcXGG-OH 
(2j), was cor-roborated by ESI-MS ([M+H]
+
= 432.3) after 
cleavage from the resin under usual conditions. The very 
same pen-tapeptide incorporating transX, H-GGtXGG-OH 
(1j) was synthesized using Fmoc-RibAFU(ip)-OH (1c) 
building block, along route B (Scheme 1) (for coupling 
efficacy see Table 1).  
Data of these syntheses were compared and analyzed in 
two ways: (i) efficiency of route A and B giving the same 
ribofuranuronic product H-GGtXGG-OH (1j) and (ii) effi-
ciency differences between the synthesis of ribofuranuronic 
H-GGtXGG-OH (1j) and xylofuranuronic H-GGcXGG-OH 
(2j) products, respectively. Comparison of the data of the two 
routes (Table 1) revealed a significant difference in the overall 
efficiency of both coupling methods in favor of route B: 42 
vs. 15 % (or 11 %) for tX. Coupling of both ribofuranuronic 
building blocks 1b and 1c indicated the same efficiency: ~86 
%. On the contrary, coupling of the ribofuranuronic building 
block (trans 1b) vs the xylofura-nuronic one (cis 2b) favored 
the trans diastereomer (76 vs. 54 % or 86 vs. 56 %). 
Consequently, the final differ-ence between route A and B 
obviously originates from the azide-phosphinimine-amine 
steps, or rather, from the difficulties of the hydrolysis of 
phosphinimines, contrary to the often used Fmoc 
deprotection. The stability of the triphenylphosphinimino 
group in Ph3P=N-cXGG-Resin as well as in the tripeptide 
Ph3P=N-cXGG-OH is unprec-edented. Generally, hydrolysis 
of any sugar phosphinimine will spontaneously take place, 
resulting in the correspond-ing aminosugar in alcoholic or 
aqueous solutions [e.g., β-d-glycopyranosyl-
triphenylphosphinimine in water afforded β-d-glycopyranosyl 
amine with excellent yield (Kovács et al.1985)]. 
 
In conclusion, –GG-tX-GG– can be synthesized in solid 
phase support using N3-tX-OH with the “milder” Ph 3P or 
the more reactive nBu3P reagent via the Staudinger reac-
tion, as well as by Fmoc-tX-OH (Table 1). Acylation with 
the N-protected sugar amino acids is of acceptable efficacy 
(76–86 %) for the trans and lower but still acceptable for 
the sterically more compact cis derivative (54–56 %). The 
subsequent acylation of these α/β-tripeptides with Fmoc-
GG-OH, resulting in the appropriate α/β-pentapeptides is 
poorer (~50 %), as a primary amine needs to be coupled. 
However, the bottleneck of the total synthesis (Scheme 3) 
is clearly the –N3 → –NH2 reduction: even with the more 
reactive nBu3P efficacy can be as low as 18 % for the cis 
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Scheme 3  Solid phase synthesis of α/β-pentapeptides. Reagents and conditions: a HOBt/DIC or HATU/DIEA; b nBu3P, THF/MeOH, rt.; c 
TEA, DIEA, THF/MeOH, RT; d Fmoc-GG-OH with HOBt/DIC or HATU/DIEA; e DCM:MeOH:AcOH (8:1:1) 
 
 
and 31 % for the trans derivatives. Below, we present a 
rational explanation of these differences by means of dif-
fraction, spectroscopic and computational data. 
 
 
As the least efficient step of the solid-phase syn-thesis is 
the otherwise attractive Staudinger reaction (–N3 to –
NH2); both 1b (N3-RibAFU(ip)-OH) and 2b 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4  Staudinger reaction of N3-RibAFU(ip)-OH and N3-XylAFU(ip)-OH as well as their derivatives, conditions: i Ph3P, pyridine; ii aq. 
NH4OH 
 
 
Table 2  Reaction of 1,2-O-
isopropylidene-3-azido-3-
deoxy-α-d-furanuronic 
compounds with Ph3P in 
solution 
 
 
 
 
O Q Products
a Conversion (yield)b 
 R 
O
    
  1     
 R2  O 
O
    
       
1b (Q: OH, R
1
: H, R
2
: N3) 1a (Q: OH, R
1
: H, R
2
: NH2) 82 % (93 %) 
    1g (Q: OH, R
1
: H, R
2
: N=PPh3) No data 
2b (Q: OH, R
1
: N3, R
2
: H) 2a (Q: OH, R
1
: NH2, R
2
: H) 81 % (94 %) 
    2g (Q: OH, R
1
: N=PPh3, R
2
: H) 49 % (25 %) 
3b (Q: NHMe, R
1
: H, R
2
: N3) 3a (Q: NHMe, R
1
: H, R
2
: NH2) 69–82 % (77–92 %) 
    3g (Q: NHMe, R
1
: H, R
2
: N=PPh3) No data 
4b (Q: NHMe, R
1
: N3, R
2
: H) 4a (Q: NHMe, R
1
: NH2, R
2
: H) 0 % 
    4g (Q: NHMe, R
1
: N=PPh3, R
2
: H) 15 % (8 %) [HCl salt 70 % (33 %)] 
5b (Q: NMe2, R
1
: N3, R
2
: H) 5a (Q: NMe2, R
1
: NH2, R
2
: H) 45 % (50 %) 
    5g (Q: NMe2, R
1
: N=PPh3, R
2
: H) 10 %  
a
  Note that the general reaction route b → a via g follows the path according to Scheme 4 
b
  Conversions and yields of amines and triphenylphosphinimines calculated from the starting azides 
 
(N3-XylAFU(ip)-OH) as well as their selected derivatives, 
N3-RibAFU(ip)-NHMe (3b) and the corresponding xylo 
epimer N3-XylAFU(ip)-NHMe (4b) were studied in solu-
tion. (The latter amide derivatives were synthesized with 
conventional amidation from 1b and 2b, and 4b and 5b 
derivatives from the reaction conducted with NHMe2.) All 
azido monomers were reacted with triphenylphosphine in 
solution under the usual conditions (Scheme 4), the inter-
mediate phosphimines were treated in situ with bases, typi-
cally with NH4OH (Scheme 4) leading to the appropriate 
product (Table 2).  
Interestingly, both C-3-epimeric (free) acids, 1b and 2b, 
when reacted in solution with Ph3P, followed by in situ 
phosphinimine hydrolysis (NH4OH/H2O, pyridine at room 
temperature) afforded the expected furanuronic acids 1a 
and 2a, respectively (yields: 93–94 %). Both products were 
isolated as white solids identified by IR and 
1
H-NMR 
spec-tra as well as with ESI-MS data.  
Both of the above reactions, 1b → 1a and 2b → 2a 
proceed via the appropriate phosphinimino-intermediate, 
 
1g and 2g. For the trans(ribo) derivative, 1g, hydrolysis is 
spontaneous and quick and thus the –N=PPh3 intermedi-
ate was not isolated, while for 2g, the cis or xylo variant 
was obtained in stable crystalline form. The higher stability 
and thus a slower hydrolysis of the 2g intermediate can be 
attributed to the intramolecular protonation of the N-atom 
of –N=PPh3 by the adjacent and particularly close –COOH 
group at C-4 (see computations below). Note that in the 
case of 1g, no such ion pair was formed in solution due to 
steric reasons, which resulted in its spontaneous hydrolysis 
and lower stability.  
The same two-step reaction from 3b lead to 3a and the 
crystalline 3-amino-3-deoxy derivative was isolated in high 
yield (92 %), characterized by IR, 
1
H-NMR and ESI-MS data. 
In contrast to the above, under similar reaction con-ditions, 4b 
afforded nothing of 3-amino-3-deoxy product 4a (0 %) and 
only traces of the intermediate triphenylphos-phinimine 4g 
were detected. In a separate experiment under modified 
conditions, 4b was transformed into the phos-phinimine 
intermediate 4g, but still in poor yield. Though 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5  Reaction conditions: a ClC(OOiBu)H, MeNH2; b Ph3P, pyridine; c aq.NH4OH; d Ph3P, Et2O; e HCl, MeOH 
 
 
obtained, 4g could be hydrolyzed into 4a not even with 
stronger bases, such as trimethylamine (TEA), N,N-diiso-
propylethylamine (DIEA) and ethanolic KOH! The unex-
pectedly high stability of 4g is further supported by the 
lack of characteristic phosphinimine reactions (e.g., with 
acetyl chloride, acetic anhydride or p-
methoxybenzaldehyde) (Gololobov 1992). Subsequently, 
the stable crystalline tri-phenylphosphiniminium salt 
4g·HCl was isolated in good yield (70 %, Scheme 5). The 
presence of the phosphin-imine substituent was 
corroborated by 
31
P-NMR spectra exhibiting characteristic 
signal of –N=PPh3 at δ 29.10 ppm and that of –NH
+
=PPh3 
at 40.55 ppm in 4g and 4g·HCl, respectively. Note that the 
target compound 4a could only be obtained as a white 
solid from 4b using nBu3P reagent instead of Ph3P.  
To elucidate the role of the carboxamido group, the 
related N,N-dimethylamide derivative 5b, N3-XylAFU(ip)-
NMe2, was synthesized from 2b under similar conditions. 
Compound 5b was treated with Ph3P in pyridine and 
subsequently hydrolyzed by aq. NH4OH to give the 
expected product 5a, H-XylAFU(ip)-NMe2. Though the 
yield of 5a was moderate, the intermediate 
 
 
triphenylphosphinimine 5g was not detected. This indi-
cates that hydrolysis of 5g takes place in essence, although 
the steric effect of the adjacent bulky dimethylcarboxam-
ido group can still hinder an external nucleophile to reach 
the central P-atom. This gives some residual stability to 5g 
as a triphenylphosphinimine, but this effect is indeed 
smaller compared to 2g or 4g.  
To better understand the stability of iminophosphoranes 
at C-3 of furanoses, conformational search and subsequent 
DFT calculations were carried out in vacuo and in water on 
2g, 4g and 5g. The structural parameters were calculated of 
these three triphenylphosphinimine compounds to explain 
the differences in their reactivity. The results of ab initio 
calculations for the conformers with carboxylic and car-
boxamide groups at C-4 of the furanoid ring, i.e., those of 
2g, 4g and 5g are summarized in Table 3.  
In case of the free acid 2g in water, the 2g_conf2 is the 
most favored structure in which the OH of the 4-COOH 
group is directed toward the ylide N-atom of the N=PPh3 
group at C-3 atom of the ring (Fig. 2a).  
This arrangement leads to the intramolecular protona-
tion of the partially negative N
δ−
-atom resulting in explicit 
 
      
  
Table 3  Ab initio determined relative energies of key phosphinimine intermediates and selected structural parameters   
      
Conformers ψ (°) dO…N (Å) dO…P (Å) G298.15 K (kcal/mol) Boltzmann distribution at 
     T = 298 K (%) 
 
 
 
Q: OH (2g) In vacuo Conf1 −47.0 4.1 5.7 4.13 0.1 
  Conf2 46.6 4.1 5.4 1.45 7.9 
  Conf3 111.2 3.3 4.3 0.00 92.0 
 In water Conf1 −35.3 4.1 5.6 1.66 5.6 
  Conf2 34.6 4.1 5.5 0.00 94.0 
  Conf3 108.3 3.3 4.4 3.31 0.3 
Q:NHMe (4g) In vacuo Conf1 −83.7 3.2 4.3 5.84 0.0 
  Conf2 121.5 3.4 3.8 0.00 100.0 
 In water Conf1 −76.0 3.3 4.7 1.16 12.4 
  Conf2 115.7 3.5 4.0 0.00 87.6 
Q: NMe2 (5g) In vacuo Conf1 −81.9 3.3 4.4 3.08 0.3 
  Conf2a 147.9 3.2 3.4 0.20 41.5 
  Conf2b 123.6 3.4 3.8 0.00 58.2 
 In water Conf1 −77.0 3.3 4.7 0.00 97.7 
  Conf2a 141.5 3.2 3.6 3.60 0.2 
  Conf2b 108.6 3.6 4.2 2.26 2.1 
 
Italics indicate the low-energy conformers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2  Graphical representation with selective NBOs of key inter-
actions in water of the lowest energy conformers of the appropriate 
phosphinimine: a 2g_conf2 (lone pair (LP) of N and antibond (BD*) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of OH), b 4g_conf2 (lone pair (LP) of O(ring) and antibond (BD*) of 
NH) and c 5g_conf1 (lone pair (LP) of O(ring)) 
 
  
  
 
P
+
-cation stabilized by the 4-COO
−
 anion (the calculated 
Mulliken charge on P is +0.16). The P 
+
-cation can be eas-
ily attacked by an external nucleophile to give the expected 
3-amino-3-deoxy product (2a, H-XylAFU(ip)-OH) in a 
fast and quantitative manner.  
In contrast to this, as in the structure of the N-methyl-
furanuronamide 4g, the O=C-NHMe group (at C-4) forms 
a N–H..O-bridge with the oxygen atom of the furanoid ring 
stabilizing 4g_conf2, in which there is no transferable 
proton for the ylide N-atom. In this conformer, the oxygen 
of the O=C group is oriented toward the partially positive 
P
δ+
-atom of the Ph3P=N group at C-3 (Fig. 2b, the calcu-
lated Mulliken charge on P is +0.38). Due to the spatial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6  Tetra-coordinated P
+
 in triphenylphosphinimine enables, 
while quasi penta-coordinated disables, hydrolysis via Nu attack 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3  Crystal structure of N-methyl-3-deoxy-3-triphenylphos-
phiniminio-1,2-O-isopropylidene-α-d-xylofuranuronamide chloride 
(4g·HCl) by X-ray diffraction. Calculated structure of 4g_conf2 in 
 
arrangement of the three phenyl substituents around the P-
atom, the equatorial N-atom of P=N along with the lone 
pairs of the carbonyl oxygen form a quasi penta-coordi-
nated structure (Scheme 6) in which the unoccupied 3s* 
orbital of the central P-atom is in axial position shadowed 
by a lone pair of the carbonyl oxygen. Lower electron den-
sity on phosphorus atom enhances this interaction. This 
quasi penta-coordinate phosphorane system leaves no pos-
sibility for an external nucleophile to attack successfully 
on this central P-atom. Consequently, hydrolysis into 3-
amino-3-deoxy product (4a, H-XylAFU(ip)-NHMe) does 
not occur due to the unexpected stability of the 
triphenylphos-phinimine compound 4g.  
The reactivity of the triphenylphosphinimino compound 
5g has been found partly similar to that of the related 2g. 
The difference is that in 5g no transferable proton is given 
for producing an explicit P
+
-cation in the Ph3P=N group at 
C-3. Furthermore, there is no possibility in –CONMe2 for 
an N–H..O-bridge to hinder the rotation of the carboxam-
ide moiety. In addition, the electron density on P allows a 
nucleophilic attack on it (Fig. 2c, the calculated Mulliken 
charge on P is +0.29). Consequently, successful hydrolysis 
to 3-amino-3-deoxy compound 5a (H-XylAFU(ip)-NMe2) 
has occurred; however, due to the steric hindrance of the 
larger O=C-NMe2 group the reaction rate is slower, com-
pared to 2g.  
The above detailed theoretical considerations concerning 
4g, namely, the quasi penta-coordinated key structure, was 
also supported by the X-ray diffraction data (Fig. 3) of its 
protonated salt (4g·HCl). Once again as in 4g_conf2, the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
water (B3LYP/6-311++G(d,p), IEFPCM solvent model//B3LYP/6-
31+G(d)). The arrows indicate the observed ROE cross-peaks 
 
 
key role of N–H..O-bridge is evident, namely its anchor-  
ing the same conformation of the CONHMe moiety (ψ
X-ray
 = 
108.9°, ψ
ab initio
 = 115.7°), positioning the O-atom of C=O 
into the vicinity of the central P-atom (d
X-ray
 = 3.9 Å, d
ab 
initio
 = 4.0 Å). This geometrical constellation makes any  
external nucleophilic attack disabling the hydrolysis 
impos-sible. Thus, the X-ray-determined crystalline 
conformer can be considered the frozen, stable and thus 
unreactive intermediate.  
Based on homonuclear 2D ROESY NMR measurements 
(CDCl3 at T = 288 K), the very same conformer in protic 
solution could be confirmed for 4g by the strong ROE 
cross-peaks of the H
δ
# and Hε# protons of the phenyl rings 
with the methyl protons of the methylamide group (Fig. 3). 
 
 
Conclusion 
 
We have shown that the –GG-X-GG– type α/β pentapep-tides, 
both the RibAFU(ip) (1a, tX) and the XylAFU(ip) variant (2a, 
cX), can be synthesized on a solid state sup-port. Though 
coupling efficacy is moderate, both the lengthier synthetic 
route using Fmoc derivative (e.g., Fmoc-RibAFU(ip)-OH) 
and the azido derivative (e.g., N3-RibAFU(ip)-OH) via 
Staudinger reaction with nBu3P can be successfully applied. 
X-ray diffraction, spectro-scopic and theoretical (QM) data 
support and explain why the application of Ph3P as 
Staudinger reagent is “ineffec-tive” in the case of the cis 
stereoisomer (N3-XylAFU(ip)-Gly-Gly-Resin) if cX is 
attached to the preceding residue with a peptide (–CONH–) 
bond. The failure of the polypep-tide chain elongation with 
N3-cX originates from the “coin-cidence” of a steric 
crowdedness and an electronic effect disabling the mandatory 
nucleophilic attack during the hydrolysis of the quasi penta-
coordinated triphenylphos-phinimine. This is in line with 
results of the reactions of the azido-furanuronic compounds 
with triphenylphosphine in solution. In spite of the herein 
revealed synthetic challenge of making α/β-chimera peptides 
on solid phase support, we have accomplished the synthesis of 
–GG-X-GG– type α/β-carbopeptides. On a new pathway 1,2-
O-isopropylidene-3-azido-3-deoxy-ribo- and -xylo-
furanuronic acids, namely that of H-RibAFU(ip)-OH (1a) and 
H-XylAFU(ip)-OH (2a) were coupled with N-protected α-
amino acids on solid phase. The herein described synthetic 
routes are general by nature and could serve as useful 
examples for further synthetic works badly needed for making 
more effectively enzyme-resistant, inherently self-assembling 
and occasion-ally nanostructure-forming α/β-peptides for drug 
discovery. 
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